Ian Judson MD

Professor Ian Judson trained at Cambridge University and King’s College Hospital Medical School. Having done a research degree at The Institute of Cancer Research, he trained in Medical Oncology at the Royal Marsden Hospital and was appointed Senior Lecturer in 1989. His research initially focused on the development of new anticancer drugs, including both laboratory research and Phase I clinical trials.

His research initially focused on the development of new anticancer drugs, including both laboratory research and Phase I clinical trials. With the advent of molecularly targeted agents it became clear that pharmacodynamic biomarker studies, including functional imaging, were vital elements of the evaluation of new anticancer agents and many trials have since emphasised the need to validate such endpoints, including studies of angiogenesis and HSP90 inhibitors.